PFIZER INC

PFE Health Care · Pharmaceuticals & Biotechnology

Latest period 2026-06-28 · 38 filings on record

Quarterly TTM Annual

8Q 3Y 5Y 10Y MAX

TTM 24-09 → TTM 26-06 8 TTM POINTS

SHOWING Trailing twelve months — each point sums the four quarters ending there.

Ranked against Health Care · 51 peers

Each grade is a single reported quarter's assessment, never an average — a card shows the grade at the newest quarter in view, so it follows the period and range controls above. Latest scored quarter: 2026-06-28.

Growth 12th pct

▼−82 over range · as of 2026-06-28

Revenue +2.6% YoY, earnings -108.5% YoY · sector avg 66

Quality 22nd pct

▼−19 over range · as of 2026-06-28

-1.6% net margin, 5% return on equity, 17% free-cash-flow margin, profitable in 6 of last 8 quarters · sector avg 45

Safety 21st pct

▲+10 over range · as of 2026-06-28

Net debt 4.6x EBITDA, 1.3x current ratio · sector avg 59

OVERVIEWvs prior TTM Δ

Trailing twelve months · ending 2026-06-28 · green = improving · click a row to chart it

Revenue $63.7B +0.6% Gross margin 73.2% −0.3pp Operating margin — — Net margin 6.8% −5.0pp Net income $4.3B −42.2%

Debt / equity 0.74 +3.7%

EPS (diluted) — — EBITDA — —

Filings

TTM 24-09 → TTM 26-06 · following the period bar 11 match

ALL 10-K 10-Q Q1 Q2 Q3 FY SORT NEWEST ↓

Filings by fiscal year and period
Year	Q1	Q2	Q3	FY
2026	10-Q Q1 2026	10-Q Q2 2026	no filing	no filing
2025	10-Q Q1 2025	10-Q Q2 2025	10-Q Q3 2025	10-K FY 2025
2024	10-Q Q1 2024	10-Q Q2 2024	10-Q Q3 2024	10-K FY 2024
2023	no filing	no filing	no filing	10-K FY 2023

10-Q Q2 2026 2026-08-04 Pro → 10-Q Q1 2026 2026-05-05 Pro → 10-K FY 2025 2026-02-26 Pro → 10-Q Q3 2025 2025-11-04 Pro → 10-Q Q2 2025 2025-08-05 Pro → 10-Q Q1 2025 2025-05-05 Pro →

All 11 filings

10-K FY 2024 2025-02-27 Pro → 10-Q Q3 2024 2024-11-04 Pro → 10-Q Q2 2024 2024-08-05 Pro → 10-Q Q1 2024 2024-05-08 Pro → 10-K FY 2023 2024-02-22 Pro →

Filing-level fact detail is a Pro feature. The grades and figures above are free. See Pro plans

Trends

Trailing twelve months, rolling one quarter at a time

Revenue

Latest$63.7B vs prior TTM+0.6% Periods8

Revenue by period
Period	Period end	Revenue
TTM 24-09	2024-09-29	$60.4B
TTM 24-12	2024-12-31	$63.6B
TTM 25-03	2025-03-30	$62.5B
TTM 25-06	2025-06-29	$63.8B
TTM 25-09	2025-09-28	$62.8B
TTM 25-12	2025-12-31	$62.6B
TTM 26-03	2026-03-29	$63.3B
TTM 26-06	2026-06-28	$63.7B

Net income

Latest$4.3B vs prior TTM−42.2% Periods8

Net income by period
Period	Period end	Net income
TTM 24-09	2024-09-29	$4.3B
TTM 24-12	2024-12-31	$8.0B
TTM 25-03	2025-03-30	$7.9B
TTM 25-06	2025-06-29	$10.8B
TTM 25-09	2025-09-28	$9.8B
TTM 25-12	2025-12-31	$7.8B
TTM 26-03	2026-03-29	$7.5B
TTM 26-06	2026-06-28	$4.3B

ZOOM

TTM 19-12 TTM 26-06

Grade history

Point-in-time: each period shows the grade of the quarter it ends at — grades are never summed or averaged across a window.

Growth 12 Quality 22 Safety 21

Hover to read every grade at a period · shared with the trends chart · axis fixed 0–100

Grade history by period
Period	Period end	Growth	Quality	Safety
TTM 24-09	2024-09-29	94	41	11
TTM 24-12	2024-12-31	92	29	26
TTM 25-03	2025-03-30	22	44	25
TTM 25-06	2025-06-29	87	46	23
TTM 25-09	2025-09-28	13	43	22
TTM 25-12	2025-12-31	4	23	19
TTM 26-03	2026-03-29	30	40	19
TTM 26-06	2026-06-28	12	22	21